IL13, one of many immune inhibitory cytokines generated by Th2 lymphocytes, is involved in tumor development by inhibiting immune surveillance functions of natural killer cells, CD4 (+) Th1 cells and CD8 (+) cytotoxic T lymphocytes [23, 24]. This evidence concerns the gene IL13 and neoplasm.